Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Peter T. Silberstein

ResearcherPublications, citations & collaboration network

Peter T. Silberstein is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 476 works, 2,678 citations, an h-index of 26 and an i10-index of 54.

476
Works
2,678
Citations
26
h-index
54
i10-index

How has Peter T. Silberstein's publication output changed over time?

ScholarIQpublication output · 1994–2024

Output grew0% over the shown period — from 1 works in 1994 to 1 in 2024.

1
1
1
1
3
1
1
1
1
199419982004200720102011201820192024

What are the most-cited papers on Peter T. Silberstein?

ScholarIQmost cited works
Phase III, Randomized, Double-Blind Study of Epoetin Alfa Compared With Placebo in Anemic Patients Receiving Chemotherapy
Thomas E. Witzig, Peter T. Silberstein, Charles L. Loprinzi, Jeff A. Sloan, Paul J. Novotny, James A. Mailliard, Kendrith M. Rowland, Steven R. Alberts, James E. Krook, Ralph Levitt, Roscoe F. Morton
Journal of Clinical Oncology. 2004209 CitationsOPEN ACCESS
Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7
Axel Grothey, Daniel A. Nikcevich, Jeff A. Sloan, John W. Kugler, Peter T. Silberstein, Todor Dentchev, Donald B. Wender, Paul J. Novotny, Umesh Chitaley, Steven R. Alberts, Charles L. Loprinzi
Journal of Clinical Oncology. 2010198 CitationsOPEN ACCESS
Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study
Patricia Mucci‐LoRusso, Barry S. Berman, Peter T. Silberstein, Marc L. Citron, Linda R. Bressler, Sharon M. Weinstein, Robert F. Kaiko, Barbara J. Buckley, Robert F. Reder
European Journal of Pain. 1998175 Citations
Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial
Amanda R. Moraska, Amit Sood, Shaker R. Dakhil, Jeff A. Sloan, Debra L. Barton, Pamela J. Atherton, Jason Suh, Patricia Griffin, David Johnson, Aneela Ali, Peter T. Silberstein, Steven F. Duane, Charles L. Loprinzi
Journal of Clinical Oncology. 2010173 CitationsOPEN ACCESS
Epidemiology of Thyroid Cancer: A Review of the National Cancer Database, 2000-2013
Evan Olson, Grant Wintheiser, Katrina M Wolfe, Jonathan Droessler, Peter T. Silberstein
Cureus. 2019143 CitationsOPEN ACCESS

Related on ScholarIQ

Creighton University
Institution
Phase III, Randomized, Double-Blind Study of Epoetin Alfa Compared With Placebo in Anemic Patients Receiving Chemotherapy
Paper
Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7
Paper
Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study
Paper
Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Long-Acting Methylphenidate for Cancer-Related Fatigue: North Central Cancer Treatment Group NCCTG-N05C7 Trial
Paper
Epidemiology of Thyroid Cancer: A Review of the National Cancer Database, 2000-2013
Paper
470M+ articles · free account